cholestyramine for oral suspension

Generic: cholestyramine for oral suspension

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cholestyramine for oral suspension
Generic Name cholestyramine for oral suspension
Labeler chartwell rx, llc
Dosage Form POWDER
Routes
ORAL
Active Ingredients

cholestyramine 4 g/5.7g

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-937
Product ID 62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074562
Listing Expiration 2026-12-31
Marketing Start 1996-08-15

Pharmacologic Class

Established (EPC)
bile acid sequestrant [epc]
Mechanism of Action
bile-acid binding activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135937
Hyphenated Format 62135-937

Supplemental Identifiers

RxCUI
848943 1801279
UPC
0362135008567 0362135937546
UNII
4B33BGI082
NUI
N0000180292 N0000175365

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cholestyramine for oral suspension (source: ndc)
Generic Name cholestyramine for oral suspension (source: ndc)
Application Number ANDA074562 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 g/5.7g
source: ndc
Packaging
  • 239.4 g in 1 CAN (62135-937-54)
source: ndc

Packages (1)

62135-937-54 239.4 g in 1 CAN (62135-937-54)

Ingredients (1)

cholestyramine (4 g/5.7g)

Linked Drug Pages (1)

Cholestyramine for Oral Suspension ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f1d8692b-deb3-d55f-e053-2a95a90ae615", "openfda": {"nui": ["N0000180292", "N0000175365"], "upc": ["0362135008567", "0362135937546"], "unii": ["4B33BGI082"], "rxcui": ["848943", "1801279"], "spl_set_id": ["80db0042-0c05-4509-8a6b-fa9f4783629a"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "239.4 g in 1 CAN (62135-937-54)", "package_ndc": "62135-937-54", "marketing_start_date": "20230103"}], "brand_name": "Cholestyramine for Oral Suspension", "product_id": "62135-937_f1d8692b-deb3-d55f-e053-2a95a90ae615", "dosage_form": "POWDER", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "62135-937", "generic_name": "Cholestyramine for Oral Suspension", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cholestyramine for Oral Suspension", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/5.7g"}], "application_number": "ANDA074562", "marketing_category": "ANDA", "marketing_start_date": "19960815", "listing_expiration_date": "20261231"}